Is there a role for circulating tumor cells in the management of breast cancer?
about
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate CancerNanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.Circulating tumor cell data: integration with imaging and serum tumor markers for metastatic breast cancer patient management.Integrating circulating tumor cell data with imaging and serum prostate-specific antigen measurement for metastatic prostate cancer therapy managementMultiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.A new method for high speed, sensitive detection of minimal residual disease.Circulating tumor cell analysis: technical and statistical considerations for application to the clinic.MUC1-positive circulating tumor cells and MUC1 protein predict chemotherapeutic efficacy in the treatment of metastatic breast cancer.Epithelial to mesenchymal transition and breast cancer.Monitoring drug-induced gammaH2AX as a pharmacodynamic biomarker in individual circulating tumor cellsPrecision medicine in breast cancer: reality or utopia?Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.Clinical significance of circulating tumor cells in breast cancer patients.Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device.Correlation between Cancer Stem Cells and Circulating Tumor Cells and Their ValueTranslational biomarkers: from preclinical to clinical a report of 2009 AAPS/ACCP Biomarker Workshop.Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.May CTC technologies promote better cancer management?Promoting quality and evidence-based care in early-stage breast cancer follow-upCirculating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.Stabilization of circulating tumor cells in blood using a collection device with a preservative reagent.DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations.Considerations in the development of circulating tumor cell technology for clinical usePrognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients.EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.The potential for liquid biopsies in the precision medical treatment of breast cancer.Detecting circulating tumor cells: current challenges and new trends.3D microfilter device for viable circulating tumor cell (CTC) enrichment from bloodIdentification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCRFull-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer.Circulating tumor cell enrichment based on physical properties.Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancerSignificance of micrometastases: circulating tumor cells and disseminated tumor cells in early breast cancer.Circulating tumor cells expressing cancer stem cell marker CD44 as a diagnostic biomarker in patients with gastric cancer.A liquid biopsy-based method for the detection and quantification of circulating tumor cells in surgical osteosarcoma patients.Detection of the circulating tumor cells in cancer patients.Circulating tumor cells as emerging tumor biomarkers in breast cancer.Breaking a vicious cycle.Rapid translation of circulating tumor cell biomarkers into clinical practice: technology development, clinical needs and regulatory requirements.
P2860
Q21296854-7FDE0699-A94D-489F-B853-B4B772E4D302Q30354652-ED31AF9D-DCEE-4CE2-B794-DF2E98E8B53FQ30815483-8BD29E59-38B1-4D5A-AEF9-FA7E4640787EQ30815486-6440C52F-F86C-4148-B905-75EAE2430082Q31006508-FD43E709-4E4B-4DA5-AF50-373977EEC1DFQ31030896-35F5AB13-B02E-45C6-94B3-D19E39D41265Q33559406-8D3D00EE-E394-4BAA-9C5A-3EFAB8B46160Q33574926-A123ADC6-96D8-482D-9FBC-6BDF3AEA362AQ33627118-40893512-A619-4CAA-B70C-756A901B81BEQ33638864-BE6F1D2F-12B8-432D-B463-466D64A50420Q33809114-73CBDA9E-B73C-47D6-A3FD-964B1D658F59Q33847889-099FD9D8-588C-41CB-AB79-D6CFB49A9761Q33879583-485B563E-1170-4BBB-8186-027AB7182D80Q34298754-BDE48070-8EF0-41BD-849F-B844C88399E6Q34440166-F5B0685A-8931-4A05-ABC9-2A86B9B4C795Q34859215-E0DFCABF-D632-4BCA-A121-F23BB672AF80Q34901063-63D06C54-4687-4470-87AC-B4964F57E5FEQ35000278-E931F8E7-AC6F-43A9-ADC0-337495E94AF4Q35016353-42EF3C3E-8652-4E28-A83D-2BADF2DE0493Q35029380-A85E4078-EAE3-4EAB-9AE1-CC837991471DQ35053624-EAE73B91-E176-437B-A55E-97BBBE8DC960Q35112470-5D032BA7-A463-4C51-AD28-B1483D8F7D76Q36268659-217B8998-8E96-420F-8938-11F7DB087DABQ36338628-55786BB5-C0FA-4678-A3E1-7489EB6FA82EQ36430451-CD7D10FB-0902-4DF1-A43E-F871443FAB59Q36689065-F4E34B15-8664-4E55-8E41-296B6F33C370Q36849660-2057F7BE-BA90-4721-ABD5-5BA25E384CF5Q36915318-2FEE6EE2-2957-4D37-986B-66CCB3D24FADQ37259934-6858CA42-A568-4093-B405-E4BF2F8EB435Q37266373-0C661101-AE0F-4DC0-B12A-CD08D2D4773FQ37277185-FC60512E-FEF3-4D47-8C5F-5169F502EE8CQ37315616-E94AFBED-AF61-4295-B5DC-96974C62CD21Q37320837-41D2A379-B068-46E6-9255-90E5D46DF6B7Q37328416-CD67400A-563D-45E1-9D4E-418F80D3181CQ37593966-DBBFBAFA-7DF6-48D4-904B-FDC421436F3AQ37718690-734965A9-5EC4-43CA-AD13-3DC8575A72D6Q37818289-353041D8-DD89-4F6D-9673-BE5BE45597C8Q37908134-C15E84D7-F04A-479F-9E10-A2D642527FDFQ38125603-C22192A7-9CDE-4695-AD94-C9B0631AED3DQ38159963-5F08B115-70CC-4B94-800A-F828DAF3B44B
P2860
Is there a role for circulating tumor cells in the management of breast cancer?
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Is there a role for circulating tumor cells in the management of breast cancer?
@ast
Is there a role for circulating tumor cells in the management of breast cancer?
@en
Is there a role for circulating tumor cells in the management of breast cancer?
@nl
type
label
Is there a role for circulating tumor cells in the management of breast cancer?
@ast
Is there a role for circulating tumor cells in the management of breast cancer?
@en
Is there a role for circulating tumor cells in the management of breast cancer?
@nl
prefLabel
Is there a role for circulating tumor cells in the management of breast cancer?
@ast
Is there a role for circulating tumor cells in the management of breast cancer?
@en
Is there a role for circulating tumor cells in the management of breast cancer?
@nl
P1476
Is there a role for circulating tumor cells in the management of breast cancer?
@en
P2093
Daniel F Hayes
Jeffrey Smerage
P304
P356
10.1158/1078-0432.CCR-07-4481
P407
P577
2008-06-01T00:00:00Z